Back to
Gavi COVAX AMC
The Gavi COVAX AMC is the innovative financing instrument that will support the participation of 92 low- and middle-income economies in the COVAX Facility – enabling access to donor-funded doses of safe and effective COVID-19 vaccines.
Learn more
Back to
The Gavi COVAX AMC Explained
Gavi’s CEO explains how its Advance Market Commitment mechanism will make COVID-19 vaccines available to lower-income countries.
By Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance
Read more
Back to
COVAX explained
COVAX has the world’s largest and most diverse portfolio of COVID-19 vaccines, and as such represents the world’s best hope of bringing the acute phase of this pandemic to a swift end.
By Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance
Learn more
Back to
José Manuel Barroso named as new Chair of the Gavi Board
Barroso: “The world needs Gavi now more than ever, both to ensure COVID-19 vaccines reach every country, rich and poor, and to press ahead with its core mission to protect hundreds of millions of people from preventable diseases.”
Read more
Back to
Annual Progress Report 2019
The successes of 2019 are a testament to the power of the Vaccine Alliance – from our core partners to the dedicated, passionate people in countries and communities upon whose hard work and expertise we rely every day to protect the next generation.
Annual Progress Report 2019
Back to
Gavi's core focus and a new five-year strategy
In June 2019, the Gavi Board approved a new five-year strategy (‘Gavi 5.0’) with a vision to ‘leave no-one behind with immunisation’ and a mission to save lives and protect people’s health by increasing equitable and sustainable use of vaccines
Learn more
